Adding covered, branded GLP-1s to a cash-pay program
A cash-pay GLP-1 program turns away, or quietly loses, the patients who would rather use their insurance. Adding a covered branded path keeps them without changing what works for everyone else. Here is the workflow and the math.
A cash-pay telehealth program can offer insurance-covered branded GLP-1s without changing how it charges for care: the visit stays cash-pay and only the medication moves to the patient’s pharmacy benefit. Add a benefits check, a licensed provider’s decision, and GLP-1 prior authorization where the plan requires it. Everyone else stays on the cash-pay path, including compounded options. In our worked model, 1,000 monthly intakes yield 62 covered patients at about $124 each in add-on costs, paid back in a little over three months.
Keep the visit cash-pay; move only the medication to insurance
A cash-pay GLP-1 program can keep insured patients by adding two steps: a benefits check, then GLP-1 prior authorization where the plan requires it. The visit stays cash-pay, and only the medication runs on the patient’s pharmacy benefit. In our worked model, 1,000 intakes a month yield 62 patients on covered branded medication, at about $124 each in add-on costs.
Without it, insured patients leave, often without asking, and you only see a lower conversion rate. The covered path doesn’t replace cash-pay: compounded GLP-1s, prescribed for a specific patient and documented to the protocol, stay right for many patients. Our overview of compounded GLP-1s in 2026 covers that side.
| Adding the covered path | Build it yourself | On Lithos |
|---|---|---|
| Benefits checks | Contract a benefits-check vendor, sign its BAA, integrate it | Usage-based add-on, no minimums |
| Prior authorization | Staff and tooling to prepare, submit and track PAs | Usage-based add-on, no minimums |
| Clinical decision | Your provider network | Licensed providers, under your protocol |
| Integrations | One more per vendor | The API you already use |
| Cash-pay and compounded path | Unchanged | Unchanged, on the same API |
How the covered path works
- Collect coverage. At intake, ask whether the patient wants to use insurance. Capture member ID, group, BIN and PCN, plus card images. Keep it optional.
- Run the benefits check. It shows whether the plan covers the medication, for which indication, whether prior authorization or step therapy applies, and the expected cost where returned.
- Make the clinical decision. A licensed provider decides whether branded medication is appropriate under your protocol and the labeling. The benefits result informs that decision; it never makes it.
- Submit the PA and fill. Send the documentation the plan’s criteria ask for. On approval, the prescription goes to a pharmacy in the plan’s network.
What does a GLP-1 benefits check tell you?
It tells you whether a prior authorization is worth submitting, so providers don’t spend time on PAs that can’t succeed.
| Benefits result | Next step |
|---|---|
| Covered, no PA required | Provider review; prescribe if appropriate |
| Covered with PA | Provider review; submit PA with documentation |
| Covered with step therapy | Check the patient’s history against the requirement |
| Not covered for this indication | Cash-pay options |
| No pharmacy coverage found | Ask the patient to confirm the card; otherwise cash-pay |
Government coverage needs care: Medicare Part D has historically excluded weight-loss drugs, Medicaid varies by state, and both are changing as of late 2026. Manufacturer copay programs are typically limited to commercially insured patients.
Write PAs criterion by criterion
Plan criteria cover the indication, clinical measurements, comorbidities and prior treatment. Answer each one directly from the chart. PAs that leave the reviewer to infer get denied for missing information, the most avoidable failure in the workflow.
- Approved: tell the patient, send the prescription to a covered pharmacy, and calendar the reauthorization date the day approval lands.
- More information requested: answer the same day if you can. Slow replies cost more days than any other step.
- Denied: if the criteria look met, appeal with complete records and a letter of medical necessity, and ask for a peer-to-peer review where offered. If the plan excludes the medication, move to cash-pay options. Appeal timelines depend on plan type and state law, so track each one.
Tell patients something at every stage
Waiting is where patients drop. Send three messages.
- At submission: what you sent, that the plan decides, and when they’ll next hear from you.
- While pending: a short status note on a regular cadence. Silence reads as a lost request.
- At decision: the outcome, the expected pharmacy cost if approved, and real options if denied.
Whether a patient starts a cash-pay option while waiting is the prescriber’s decision under your protocol.
Coverage changes at renewal and with new jobs; make moving between paths easy.
What 1,000 intakes a month produce
All figures are illustrative. The add-on costs are placeholders, not published rates.
| Step | Assumption | Patients |
|---|---|---|
| Report insurance they want to use | 35% | 350 benefits checks |
| Plan covers the medication for the indication | 40% | 140 |
| Provider finds branded appropriate; patient wants it | 85% | 119 PAs |
| Approved on first submission | 50% | 60 |
| Of 59 denials | 30 appealed, 30% overturned | 9 more |
| Approved and filled | 90% of 69 | 62 patients |
At $5 per benefits check and $50 per PA, that’s 350 × $5 plus 119 × $50: $7,700 a month, or about $124 per covered patient.
Say those patients pay a $49 monthly membership with one async follow-up a quarter. A program at 1,000 intakes is already past 1,000 visits a month, and Lithos pay-as-you-go pricing is graduated, so each added visit is billed at $30 async, or $10 a month. After 3% payments, contribution is $37.53 a month. The $124 pays back in a little over three months.
Some of the 62 would have bought cash-pay anyway; if half would have, the path adds 31 patients a month. The other 288 insured patients get a clear next step. Measure insured-patient conversion before and after launch.
Send us last month’s intake numbers and the share of patients who asked about insurance, and we’ll build this funnel with you on a call. Book a call.
Launch checklist
- Add optional coverage questions and card capture to intake.
- Decide who runs benefits checks and PAs, and who owns follow-up.
- Update the protocol: when branded is appropriate, what the chart must document, how reauthorization works.
- Write the routing table and a patient message for each stage.
- Train support on pending versus denied PAs.
- Instrument checks, coverage rate, submissions, approvals, appeals, fills and path changes.
The same cohort math applies to adding a second vertical. If the covered path changes your membership price, see our guide to pricing GLP-1 subscriptions.
Lithos supports cash-pay and insurance-covered, compounded and branded paths behind one API. Branded prescriptions such as Wegovy go through insurance benefits checks and prior authorization, usage-based add-ons with no minimums, while licensed providers make every clinical decision under your protocol. Tell us your monthly volume and we’ll price your visits plus the add-ons on a call, then map the covered path into your intake. See how it fits programs adding services, or book a call.
Frequently asked questions
Can a cash-pay telehealth program prescribe branded GLP-1s covered by insurance?
Yes. The visit stays cash-pay while the medication is covered under the patient’s pharmacy benefit. The program runs a benefits check, a licensed provider decides whether branded medication is appropriate, and a prior authorization goes in when the plan requires one.
What does a GLP-1 benefits check tell you?
A GLP-1 benefits check shows whether the patient’s plan covers the medication, whether coverage depends on the indication, whether prior authorization or step therapy is required, and, where the plan returns it, the patient’s expected cost. It doesn’t guarantee approval. Its job is to tell you whether a prior authorization is worth submitting.
How long does GLP-1 prior authorization take?
It varies by plan, and decision windows depend on plan type and state law, so don’t promise patients a date. Promise regular status updates, answer requests for more information fast, and record the approval period so reauthorization starts before it lapses.
What happens when a GLP-1 prior authorization is denied?
Read the denial reason first. If the criteria look met and documentation was missing, appeal with complete records and a letter of medical necessity, and ask for a peer-to-peer review where offered. If the plan excludes the medication or indication, an appeal rarely helps; discuss cash-pay options instead.
Does adding branded GLP-1s hurt a compounded GLP-1 program?
It shouldn’t, if routing is clear. Covered branded medication serves patients whose plans cover it; cash-pay options, including compounded medication a provider prescribes for a specific patient, serve everyone else. Offering both keeps insured patients who would otherwise leave.
Get the Journal by email
Our best guides on building compliant telehealth programs — a couple a week, unsubscribe any time.
Put a medical practice behind your product
Book a call and we'll scope your program together, or get free sandbox access and start building.